Cardura Xl

Product manufactured by Roerig

Application Nr Approved Date Route Status External Links
NDA021269 2005-02-22 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cardura® Xl (doxazosin Mesylate Extended Release Tablets) Is Indicated For The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia (bph). Cardura Xl Is Not Indicated For The Treatment Of Hypertension. Cardura Xl Is An Alpha1 Adrenergic Antagonist Indicated For The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia. (1) Cardura Xl Is Not Indicated For The Treatment Of Hypertension. (1)

All Formulated Excipients (7 Total)

Name Structure Kind Function Status
1. Sodium Chloride SODIUM CHLORIDE Unresolved GRAS-Generally recognized as safe.
2. Hypromelloses HYPROMELLOSES Unresolved
3. Ferric Oxide Red FERRIC OXIDE RED Molecular
4. Titanium Dioxide TITANIUM DIOXIDE Unresolved DYE-Dye
5. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
6. Cellulose Acetate CELLULOSE ACETATE Unresolved
7. Shellac SHELLAC Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Doxazosin Mesylate DOXAZOSIN MESYLATE ZINC94566092

Comments